- Home
- Galakatos Nicholas
Insider Trading History of Galakatos Nicholas
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Galakatos Nicholas since 2005.
The trader's CIK number is 1252522.
At the time of the last reporting, Galakatos Nicholas was the 10% Owner of Entasis Therapeutics Holdings Inc.. (stock ticker symbol ETTX).
Also see all insider trading activities at Entasis Therapeutics Holdings Inc..
Note that in the past
GALAKATOS NICHOLAS also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cryocor Inc (CRYO) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | CRYO | 96,551 | $496,272 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nanostring Technologies Inc (NSTG) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | NSTG | 0 | $0 | 85,823 | $1,372,309 | 0 | $0 |
Yearly summary of insider trading at Critical Therapeutics Inc (CRTX) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | CRTX | 547,446 | $3,000,004 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Portola Pharmaceuticals Inc (PTLA) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | PTLA | 0 | $0 | 1,369 | $31,979 | 0 | $0 |
Yearly summary of insider trading at Catabasis Pharmaceuticals Inc (CATB) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | CATB | 376,695 | $4,520,340 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Iveric Bio, Inc. (OPHT) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | OPHT | 0 | $0 | 3,000 | $196,920 | 0 | $0 |
| 2015 | OPHT | 0 | $0 | 9,000 | $541,839 | 0 | $0 |
| 2014 | OPHT | 0 | $0 | 144,976 | $6,404,140 | 0 | $0 |
| 2013 | OPHT | 5,000 | $110,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Metabasis Therapeutics Inc (MBRX) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | MBRX | 71,866 | $168,166 | 0 | $0 | 0 | $0 |
| 2005 | MBRX | 699,659 | $4,100,001 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Entasis Therapeutics Holdings Inc. (ETTX) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ETTX | 453,395 | $6,800,925 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Senorx Inc (SENO) by Galakatos Nicholas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | SENO | 0 | $0 | 256,504 | $2,770,038 | 0 | $0 |
Insider trading activities at 9 companies by Galakatos Nicholas:
1. Cryocor Inc (CRYO)
2. Nanostring Technologies Inc (NSTG)
3. Critical Therapeutics Inc (CRTX)
4. Portola Pharmaceuticals Inc (PTLA)
5. Catabasis Pharmaceuticals Inc (CATB)
6. Iveric Bio, Inc. (OPHT)
7. Metabasis Therapeutics Inc (MBRX)
8. Entasis Therapeutics Holdings Inc. (ETTX)
9. Senorx Inc (SENO)
Table 1. Insider trading of Cryocor Inc (CRYO) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-04-24 | CRYO | Buy | 96,551 | 5.14 | 496,272 |
Table 2. Insider trading of Nanostring Technologies Inc (NSTG) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-09-17 | NSTG | Sale | 85,823 | 15.99 | 1,372,309 |
Table 3. Insider trading of Critical Therapeutics Inc (CRTX) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-06-20 | CRTX | Buy | 547,446 | 5.48 | 3,000,004 |
Table 4. Insider trading of Portola Pharmaceuticals Inc (PTLA) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-06-10 | PTLA | Sale | 1,369 | 23.36 | 31,979 |
Table 5. Insider trading of Catabasis Pharmaceuticals Inc (CATB) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-30 | CATB | Buy | 376,695 | 12.00 | 4,520,340 |
Table 6. Insider trading of Iveric Bio, Inc. (OPHT) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-11 | OPHT | Sale | 3,000 | 65.64 | 196,920 |
| 2015-12-10 | OPHT | Sale | 3,000 | 64.27 | 192,804 |
| 2015-11-18 | OPHT | Sale | 1,500 | 60.00 | 90,000 |
| 2015-11-10 | OPHT | Sale | 1,500 | 58.69 | 88,035 |
| 2015-11-09 | OPHT | Sale | 1,500 | 60.00 | 90,000 |
| 2015-11-02 | OPHT | Sale | 1,500 | 54.00 | 81,000 |
| 2014-06-12 | OPHT | Sale | 47,217 | 44.51 | 2,101,675 |
| 2014-06-13 | OPHT | Sale | 82,277 | 44.01 | 3,621,257 |
| 2014-06-16 | OPHT | Sale | 15,482 | 44.00 | 681,208 |
| 2013-09-30 | OPHT | Buy | 5,000 | 22.00 | 110,000 |
Table 7. Insider trading of Metabasis Therapeutics Inc (MBRX) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-04-16 | MBRX | Buy | 71,866 | 2.34 | 168,166 |
| 2005-09-30 | MBRX | Buy | 699,659 | 5.86 | 4,100,001 |
Table 8. Insider trading of Entasis Therapeutics Holdings Inc. (ETTX) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-09-28 | ETTX | Buy | 453,395 | 15.00 | 6,800,925 |
Table 9. Insider trading of Senorx Inc (SENO) by Galakatos Nicholas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-06-25 | SENO | Sale | 161,293 | 10.97 | 1,769,384 |
| 2010-06-28 | SENO | Sale | 46,600 | 10.97 | 511,202 |
| 2010-04-26 | SENO | Sale | 1,000 | 10.05 | 10,050 |
| 2010-04-27 | SENO | Sale | 13,900 | 10.09 | 140,251 |
| 2010-04-23 | SENO | Sale | 1,900 | 10.07 | 19,133 |
| 2010-04-22 | SENO | Sale | 31,811 | 10.06 | 320,018 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Galakatos Nicholas
(10% Owner of Entasis Therapeutics Holdings Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.